ARCHIVES

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

This article is from The Cancer Letter archive.

Vol. 20 No. 33 | August 19, 1994

Download PDF Visit The Full Archive

Related Articles

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

Funding Opportunities: RFA: Cancer Research Network Across Health Care Systems

September 12, 1997

NIH News: Varmus Presents “Modest Proposal for a Simpler NIH”

August 6, 1999

Funding Opportunities.

May 24, 2002

Funding Opporunities: Program Announcments

January 15, 1999

In Brief: Levine Leaves NIH For Pittsburgh; Fischbach Leaves Harvard For NIH; NCI Researcher Dies

June 12, 1998